Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: RAMM Pharma Corp.

Market Cap 1.79M 1.28M 1.1M 1.01M 953K 120M 1.81M 12M 4.67M 59.13M 4.79M 4.69M 205M P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 1.07M 761K 656K 603K 568K 71.81M 1.08M 7.15M 2.78M 35.24M 2.86M 2.79M 122M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 30/09/2019
Director of Finance/CFO - 08/12/2022
Director TitleAgeSince
Director/Board Member - 30/09/2019
Director/Board Member 82 30/09/2019
Director/Board Member 66 30/09/2019
Change 5-day change 1-year change 3-year change Capi.($)
-76.29%-92.33% - - 1.28M
-0.94%-2.14%+40.54%+148.38% 992B
-0.42%-1.80%+53.69%+42.60% 564B
-0.56%-1.65%+19.27%+59.57% 391B
-1.18%+0.68%+24.66%+16.53% 330B
+1.42%+0.06%+26.36%+14.29% 280B
+1.09%+1.65%+26.61%+33.32% 279B
+1.87%+0.87%-41.49%-48.26% 196B
-1.78%+1.16%+17.79%+48.77% 184B
-1.40%+3.27%+16.16%+59.08% 156B
Average -7.82%+0.41%+20.40%+41.59% 374.58B
Weighted average by Cap. -0.37%-0.49%+29.25%+65.83%

Financials

2024 2025
Net sales 4.34M 3.1M 2.67M 2.45M 2.31M 292M 4.38M 29.09M 11.33M 143M 11.62M 11.37M 496M 3.36M 2.4M 2.07M 1.9M 1.79M 226M 3.39M 22.52M 8.77M 111M 8.99M 8.8M 384M
Net income -16.5M -11.76M -10.15M -9.33M -8.78M -1.11B -16.64M -111M -43.05M -545M -44.15M -43.21M -1.88B -8.91M -6.35M -5.48M -5.04M -4.74M -599M -8.98M -59.7M -23.24M -294M -23.84M -23.33M -1.02B
Net Debt -626K -446K -385K -354K -333K -42.1M -631K -4.19M -1.63M -20.66M -1.67M -1.64M -71.47M -723K -516K -445K -409K -385K -48.67M -730K -4.85M -1.89M -23.89M -1.94M -1.89M -82.64M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!